Can olanzapine be implicated in causing serotonin syndrome? (Q44112650)

29 November 2017

title

Can olanzapine be implicated in causing serotonin syndrome? (English)

1 reference

29 November 2017

0 references

Christopher David Haslett

series ordinal

1 reference

29 November 2017

Shailesh Kumar

series ordinal

1 reference

29 November 2017

publication date

1 October 2002

1 reference

Psychiatry and Clinical Neurosciences

29 November 2017

published in

1 reference

29 November 2017

1 reference

29 November 2017

1 reference

29 November 2017

page(s)

533-535

1 reference

The place of anticonvulsant therapy in bipolar illness

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01050.X

Concurrent use of more than one major psychotropic drug (polypsychopharmacy) in out-patients--a prescription database study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01050.X

21 January 2018

The serotonin syndrome

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01050.X

Effect of subchronic lithium treatment on citalopram-induced increases in extracellular concentrations of serotonin in the medial prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01050.X

Comments on "Serotonin syndrome during treatment with paroxetine and risperidone".

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01050.X

The serotonin syndrome and its treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01050.X

Radioreceptor binding profile of the atypical antipsychotic olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01050.X

5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01050.X

The enhancement by lithium of the 5-HT1A mediated serotonin syndrome produced by 8-OH-DPAT in the rat: evidence for a post-synaptic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01050.X

5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01050.X

Possible serotonin syndrome in association with 5-HT(3) antagonist agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01050.X

Serotonin Syndrome During Treatment With Paroxetine and Risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1819.2002.01050.X

10.1046/J.1440-1819.2002.01050.X

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference